This article is more than 5 years old. Information may no longer be current.
Widefield fluorescein digital angiography allows aggressive treatment in pediatric cases
Click Here to Manage Email Alerts
KOLOA, Hawaii — Fluorescein guided treatment of pediatric retinal cases allows aggressive treatment to control disease, according to a speaker here.
Widefield digital fluorescein angiography is now incorporated in all cases of pediatric peripheral vitreoretinal pathology at Bascom Palmer Eye Institute, Audina M. Berrocal, MD, told colleagues at Retina 2014. Such disorders include Coats’ disease, familial exudative vitreoretinopathy, incontinentia pigmenti, persistent fetal vasculature, retinopathy of prematurity, shaken baby syndrome and congenital glaucoma.
Audina M. Berrocal
“Fluorescein agngiography in these cases really enables us to enhance the diagnostic accuracy, improve targeted retina treatments, heighten recognition of early progression and document treatment response,” Berrocal said.
Before widefield digital angiography, assessment depended solely on clinical examination to determine areas affected by disease, avascularity of the retina and recurrence of disease, she said.
The modality guides treatment and allows visualization of areas that were not previously obvious, she said, allowing her to treat aggressively and control the disease.
In the more than 200 infants imaged, no significant complications have been associated with use of widefield fluorescein angiography intraoperatively or in the neonatal intensive care unit at Bascom Palmer, she said. —by Patricia Nale
Disclosure: Berrocal is a consultant for Alcon Laboratories, Inc., Clarity Medical Systems and ThromboGenics.